PMID- 10385618
OWN - NLM
STAT- MEDLINE
DCOM- 19990805
LR  - 20190516
IS  - 0890-9369 (Print)
IS  - 0890-9369 (Linking)
VI  - 13
IP  - 12
DP  - 1999 Jun 15
TI  - CDK inhibitors: positive and negative regulators of G1-phase progression.
PG  - 1501-12
FAU - Sherr, C J
AU  - Sherr CJ
AD  - Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude
      Children's Research Hospital, Memphis, Tennessee 38105, USA. sherr@stjude.org
FAU - Roberts, J M
AU  - Roberts JM
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Genes Dev
JT  - Genes & development
JID - 8711660
RN  - 0 (CDKN1A protein, human)
RN  - 0 (CDKN2D protein, human)
RN  - 0 (Carrier Proteins)
RN  - 0 (Cell Cycle Proteins)
RN  - 0 (Cyclin D)
RN  - 0 (Cyclin E)
RN  - 0 (Cyclin-Dependent Kinase Inhibitor p16)
RN  - 0 (Cyclin-Dependent Kinase Inhibitor p19)
RN  - 0 (Cyclin-Dependent Kinase Inhibitor p21)
RN  - 0 (Cyclins)
RN  - 0 (Enzyme Inhibitors)
RN  - 0 (Holoenzymes)
RN  - 0 (Microtubule-Associated Proteins)
RN  - 0 (Tumor Suppressor Proteins)
RN  - 147604-94-2 (Cyclin-Dependent Kinase Inhibitor p27)
RN  - EC 2.7.11.22 (Cyclin-Dependent Kinases)
SB  - IM
MH  - Animals
MH  - Carrier Proteins/metabolism
MH  - Catalysis
MH  - Cell Cycle
MH  - *Cell Cycle Proteins
MH  - Cyclin D
MH  - Cyclin E/metabolism
MH  - *Cyclin-Dependent Kinase Inhibitor p16
MH  - Cyclin-Dependent Kinase Inhibitor p19
MH  - Cyclin-Dependent Kinase Inhibitor p21
MH  - Cyclin-Dependent Kinase Inhibitor p27
MH  - Cyclin-Dependent Kinases/*antagonists & inhibitors
MH  - Cyclins/*metabolism
MH  - Enzyme Inhibitors/*metabolism
MH  - *G1 Phase
MH  - Holoenzymes/metabolism
MH  - Humans
MH  - Microtubule-Associated Proteins/*metabolism
MH  - Neoplasms/metabolism/pathology
MH  - *Tumor Suppressor Proteins
RF  - 148
EDAT- 1999/07/01 00:00
MHDA- 1999/07/01 00:01
CRDT- 1999/07/01 00:00
PHST- 1999/07/01 00:00 [pubmed]
PHST- 1999/07/01 00:01 [medline]
PHST- 1999/07/01 00:00 [entrez]
AID - 10.1101/gad.13.12.1501 [doi]
PST - ppublish
SO  - Genes Dev. 1999 Jun 15;13(12):1501-12. doi: 10.1101/gad.13.12.1501.